low hba1c level	0	1.6	2	Be aware that there are other possible reasons for a low HbA1c level, for example, deteriorating renal function or sudden weight loss.	Be aware that there are other possible reasons for a low HbA1c level, for example, deteriorating renal function or sudden weight loss.	
sudden weight loss	0	1.6	2	Be aware that there are other possible reasons for a low HbA1c level, for example, deteriorating renal function or sudden weight loss.	Be aware that there are other possible reasons for a low HbA1c level, for example, deteriorating renal function or sudden weight loss.	
blood glucose levels	0	1.4296	2	Do not routinely offer self-monitoring of blood glucose levels for adults with type 2 diabetes unless: the person is on insulin or there is evidence of hypoglycaemic episodes or the person is on oral medication that may increase their risk of hypoglycaemia while driving or operating machinery or the person is pregnant, or is planning to become pregnant.	Consider short-term self-monitoring of blood glucose levels in adults with type 2 diabetes (and review treatment as necessary): when starting treatment with oral or intravenous corticosteroids or to confirm suspected hypoglycaemia.	
caribbean family origin	0	1.4296	2	Exceptions to this are people of African or Caribbean family origin, or women for whom there is a possibility of becoming pregnant.	The first-line antihypertensive drug treatment for a person of African or Caribbean family origin should be an ACE inhibitor plus either a diuretic or a generic calcium-channel blocker.	
problematic erectile dysfunction	0	1.4296	2	Assess, educate and support men with type 2 diabetes who have problematic erectile dysfunction, addressing contributory factors such as cardiovascular disease as well as possible treatment options.	Consider a phosphodiesterase-5 inhibitor to treat problematic erectile dysfunction in men with type 2 diabetes, initially choosing the drug with the lowest acquisition cost and taking into account any contraindications.	
antihypertensive drug treatments	0	1.3333	1	When using tricyclic drugs and antihypertensive drug treatments in adults with type 2 diabetes who have autonomic neuropathy, be aware of the increased likelihood of side effects such as orthostatic hypotension.	
arrange emergency review	0	1.3333	1	Arrange emergency review by an ophthalmologist for: sudden loss of vision rubeosis iridis pre-retinal or vitreous haemorrhage retinal detachment.	
arrange rapid review	0	1.3333	1	Arrange rapid review by an ophthalmologist for new vessel formation.	
autonomic neuropathy symptoms	0	1.3333	1	In managing autonomic neuropathy symptoms, include specific interventions indicated by the manifestations (for example, for abnormal sweating or nocturnal diarrhoea).	
blood glucose control	0	1.3333	1	Think about a diagnosis of gastroparesis in adults with type 2 diabetes with erratic blood glucose control or unexplained gastric bloating or vomiting, taking into account possible alternative diagnoses.	
blood pressure control	0	1.3333	1	For an adult with type 2 diabetes on antihypertensive drug treatment when diabetes is diagnosed, review blood pressure control and medications used.	
blood pressure target	0	1.3333	1	Monitor the blood pressure of a person who has attained and consistently remained at his or her blood pressure target every 4–6 months.	
body weight loss	0	1.3333	1	For adults with type 2 diabetes who are overweight, set an initial body weight loss target of 5–10percent.	
current drug treatment	0	1.3333	1	Make changes only if there is poor control or if current drug treatment is not appropriate because of microvascular complications or metabolic problems.	
diabetes management plan	0	1.3333	1	Integrate dietary advice with a personalised diabetes management plan, including other aspects of lifestyle modification, such as increasing physical activity and losing weight.	
diabetic peripheral neuropathy	0	1.3333	1	For guidance on managing painful diabetic peripheral neuropathy in adults with type 2 diabetes, see the NICE guideline on neuropathic pain in adults.	
digital retinal photography	0	1.3333	1	Use a quality-assured digital retinal photography programme using appropriately trained staff.	
erratic blood glucose	0	1.3333	1	Think about a diagnosis of gastroparesis in adults with type 2 diabetes with erratic blood glucose control or unexplained gastric bloating or vomiting, taking into account possible alternative diagnoses.	
excess energy intake	0	1.3333	1	Advise adults with type 2 diabetes that limited substitution of sucrose-containing foods for other carbohydrate in the meal plan is allowable, but that they should take care to avoid excess energy intake.	
eye screening programmes	0	1.3333	1	Perform visual acuity testing as a routine part of eye screening programmes.	
eye screening service	0	1.3333	1	On diagnosis, GPs should immediately refer adults with type 2 diabetes to the local eye screening service.	
eye screening systems	0	1.3333	1	Explain the reasons for, and success of, eye screening systems to adults with type 2 diabetes, so that attendance is not reduced by lack of knowledge or fear of outcome.	
generic angiotensin-converting enzyme	0	1.3333	1	First-line antihypertensive drug treatment should be a once-daily, generic angiotensin-converting enzyme (ACE) inhibitor.	
generic calcium-channel blocker	0	1.3333	1	The first-line antihypertensive drug treatment for a person of African or Caribbean family origin should be an ACE inhibitor plus either a diuretic or a generic calcium-channel blocker.	
haemorrhage retinal detachment	0	1.3333	1	Arrange emergency review by an ophthalmologist for: sudden loss of vision rubeosis iridis pre-retinal or vitreous haemorrhage retinal detachment.	
healthy balanced eating	0	1.3333	1	Emphasise advice on healthy balanced eating that is applicable to the general population when providing advice to adults with type 2 diabetes.	
individual hba1c target	0	1.3333	1	Involve adults with type 2 diabetes in decisions about their individual HbA1c target.	
initial body weight	0	1.3333	1	For adults with type 2 diabetes who are overweight, set an initial body weight loss target of 5–10percent.	
integrate dietary advice	0	1.3333	1	Integrate dietary advice with a personalised diabetes management plan, including other aspects of lifestyle modification, such as increasing physical activity and losing weight.	
investigate unexplained discrepancies	0	1.3333	1	Investigate unexplained discrepancies between HbA1c and other glucose measurements.	
local eye screening	0	1.3333	1	On diagnosis, GPs should immediately refer adults with type 2 diabetes to the local eye screening service.	
low blood pressure	0	1.3333	1	Check for possible adverse effects of antihypertensive drug treatment – including the risks from unnecessarily low blood pressure.	
low-fat dairy products	0	1.3333	1	Encourage high-fibre, low-glycaemic-index sources of carbohydrate in the diet, such as fruit, vegetables, wholegrains and pulses; include low-fat dairy products and oily fish; and control the intake of foods containing saturated and trans fatty acids.	
meal planning system	0	1.3333	1	When adults with type 2 diabetes are admitted to hospital as inpatients or to any other care setting, implement a meal planning system that provides consistency in the carbohydrate content of meals and snacks.	
measure blood pressure	0	1.3333	1	Measure blood pressure at least annually in an adult with type 2 diabetes without previously diagnosed hypertension or renal disease.	
nervous system damage	0	1.3333	1	Think about the possibility of contributory sympathetic nervous system damage for adults with type 2 diabetes who lose the warning signs of hypoglycaemia.	
ongoing nutritional advice	0	1.3333	1	Provide individualised and ongoing nutritional advice from a healthcare professional with specific expertise and competencies in nutrition.	
perform visual acuity	0	1.3333	1	Perform visual acuity testing as a routine part of eye screening programmes.	
preventive lifestyle advice	0	1.3333	1	Offer and reinforce preventive lifestyle advice.	
retinal photography programme	0	1.3333	1	Use a quality-assured digital retinal photography programme using appropriately trained staff.	
structured eye screening	0	1.3333	2	Arrange repeat structured eye screening annually.	Depending on the findings, follow structured eye screening by: routine review in 1 year or earlier review or referral to an ophthalmologist.	
sympathetic nervous system	0	1.3333	1	Think about the possibility of contributory sympathetic nervous system damage for adults with type 2 diabetes who lose the warning signs of hypoglycaemia.	
unexplained bladder-emptying problems	0	1.3333	1	Investigate the possibility of autonomic neuropathy affecting the bladder in adults with type 2 diabetes who have unexplained bladder-emptying problems.	
vision rubeosis iridis	0	1.3333	1	Arrange emergency review by an ophthalmologist for: sudden loss of vision rubeosis iridis pre-retinal or vitreous haemorrhage retinal detachment.	
visual acuity testing	0	1.3333	1	Perform visual acuity testing as a routine part of eye screening programmes.	
vitreous haemorrhage retinal	0	1.3333	1	Arrange emergency review by an ophthalmologist for: sudden loss of vision rubeosis iridis pre-retinal or vitreous haemorrhage retinal detachment.	
weight loss target	0	1.3333	1	For adults with type 2 diabetes who are overweight, set an initial body weight loss target of 5–10percent.	
angiotensin ii-receptor antagonist	0	1.2985	3	For a person with continuing intolerance to an ACE inhibitor (other than renal deterioration or hyperkalaemia), substitute an angiotensin II-receptor antagonist for the ACE inhibitor.	Do not combine an ACE inhibitor with an angiotensin II-receptor antagonist to treat hypertension.	If the person's blood pressure is not reduced to the individually agreed target with triple therapy, add an alpha-blocker, a beta-blocker or a potassium-sparing diuretic (the last with caution if the person is already taking an ACE inhibitor or an angiotensin II-receptor antagonist).	
first-line antihypertensive drug	0	1.2985	3	First-line antihypertensive drug treatment should be a once-daily, generic angiotensin-converting enzyme (ACE) inhibitor.	The first-line antihypertensive drug treatment for a person of African or Caribbean family origin should be an ACE inhibitor plus either a diuretic or a generic calcium-channel blocker.	A calcium-channel blocker should be the first-line antihypertensive drug treatment for a woman for whom, after an informed discussion, it is agreed there is a possibility of her becoming pregnant	
antihypertensive drug treatment	0	1.0783	7	For an adult with type 2 diabetes on antihypertensive drug treatment when diabetes is diagnosed, review blood pressure control and medications used.	Monitor blood pressure every 1–2 months, and intensify therapy if the person is already on antihypertensive drug treatment, until the blood pressure is consistently below 140 80 mmHg (below 130 80 mmHg if there is kidney, eye or cerebrovascular damage).	First-line antihypertensive drug treatment should be a once-daily, generic angiotensin-converting enzyme (ACE) inhibitor.	The first-line antihypertensive drug treatment for a person of African or Caribbean family origin should be an ACE inhibitor plus either a diuretic or a generic calcium-channel blocker.	A calcium-channel blocker should be the first-line antihypertensive drug treatment for a woman for whom, after an informed discussion, it is agreed there is a possibility of her becoming pregnant	Check for possible adverse effects of antihypertensive drug treatment – including the risks from unnecessarily low blood pressure.	When using tricyclic drugs and antihypertensive drug treatments in adults with type 2 diabetes who have autonomic neuropathy, be aware of the increased likelihood of side effects such as orthostatic hypotension.	
diabetes healthcare team	0	1.0666	1	Ensure that all members of the diabetes healthcare team are familiar with the patient-education programmes available locally, that these programmes are integrated with the rest of the care pathway, and that adults with type 2 diabetes and their family members or carers (as appropriate) have the opportunity to contribute to the design and provision of local programmes.	
structured education programme	0	1.011	1	Ensure that any structured education programme for adults with type 2 diabetes includes the following components: It is evidence-based, and suits the needs of the person. It has specific aims and learning objectives, and supports the person and their family members and carers in developing attitudes, beliefs, knowledge and skills to self-manage diabetes. It has a structured curriculum that is theory-driven, evidence-based and resource-effective, has supporting materials, and is written down. It is delivered by trained educators who have an understanding of educational theory appropriate to the age and needs of the person, and who are trained and competent to deliver the principles and content of the programme. It is quality assured, and reviewed by trained, competent, independent assessors who measure it against criteria that ensure consistency. The outcomes are audited regularly.	
monitor blood pressure	0	1.0007	1	Monitor blood pressure every 1–2 months, and intensify therapy if the person is already on antihypertensive drug treatment, until the blood pressure is consistently below 140 80 mmHg (below 130 80 mmHg if there is kidney, eye or cerebrovascular damage).	
advantageous metabolic impact	0	0.956	1	Remember that lesser degrees of weight loss may still be of benefit, and that larger degrees of weight loss in the longer term will have advantageous metabolic impact.	
chronic kidney disease	0	0.922	1	For guidance on managing kidney disease in adults with type 2 diabetes, see the NICE guideline on chronic kidney disease in adults.	
diabetic foot problems	0	0.922	1	For guidance on preventing and managing foot problems in adults with type 2 diabetes, see the NICE guideline on diabetic foot problems.	
group education programmes	0	0.9177	1	Offer group education programmes as the preferred option. Provide an alternative of equal standard for a person unable or unwilling to participate in group education.	
offer group education	0	0.9177	1	Offer group education programmes as the preferred option. Provide an alternative of equal standard for a person unable or unwilling to participate in group education.	
excess weight gain	0	0.6536	1	For recommendations on lifestyle advice, see the NICE guidelines on: preventing excess weight gain, weight management, obesity, physical activity, smoking: brief interventions and referrals, stop smoking services, smoking: harm reduction, and smoking: acute, maternity and mental health services.	
mental health services	1	0.6536	1	For recommendations on lifestyle advice, see the NICE guidelines on: preventing excess weight gain, weight management, obesity, physical activity, smoking: brief interventions and referrals, stop smoking services, smoking: harm reduction, and smoking: acute, maternity and mental health services.	
cotton wool spots	0	0.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
intraretinal microvascular abnormalities	0	0.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
national screening committee	0	0.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
referable pre-proliferative retinopathy	0	0.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
screening committee criteria	0	0.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
sudden unexplained drop	0	0.0	1	Refer to an ophthalmologist in accordance with the National Screening Committee criteria and timelines if any of these features are present: referable maculopathy: exudate or retinal thickening within 1 disc diameter of the centre of the fovea circinate or group of exudates within the macula (the macula is defined here as a circle centred on the fovea, with a diameter the distance between the temporal border of the optic disc and the fovea) any microaneurysm or haemorrhage within 1 disc diameter of the centre of the fovea, only if associated with deterioration of best visual acuity to 6 12 or worse. referable pre-proliferative retinopathy (if cotton wool spots are present, look carefully for the following features, but cotton wool spots themselves do not define pre-proliferative retinopathy): any venous beading any venous reduplication any intraretinal microvascular abnormalities multiple deep, round or blot haemorrhages. any large, sudden unexplained drop in visual acuity.	
